Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × PHY 906 × Clear all

NCT00036517 2005-06-24

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Diarrhea, Colorectal Neoplasms